Topas Therapeutics GmbH Email Format

Biotechnology ResearchHamburg, Germany11-50 Employees

Topas Therapeutics GmbH is a clinical-stage biotechnology company focused on developing immune tolerance therapies for autoimmune diseases. Its approach uses a targeted nanoparticle platform to present antigens in a way that promotes T cell tolerance, leveraging liver-associated mechanisms to modulate immune responses in a controlled, antigen-specific manner. The company aims to treat autoimmune conditions by inducing systemic tolerance across a broad range of disease-relevant antigens, with a pipeline that reflects ongoing advancement through clinical development. Based in Hamburg, Germany, the team operates within the biotechnology research sector and engages in activities appropriate to advancing experimental therapies toward clinical evaluation. The firm is active in presenting its platform and progress at scientific conferences and industry events, reflecting its participation in the broader immunology and autoimmune disease research community.

Sign up for free to view info

Company overview Employee directory